Overview

Tofacitinib For Treatment Of Chronic Pouchitis

Status:
Recruiting
Trial end date:
2022-02-01
Target enrollment:
Participant gender:
Summary
A phase 2 pilot study to evaluate the effectiveness of tofacitinib in subjects with chronic pouchitis
Phase:
Phase 2
Details
Lead Sponsor:
Cedars-Sinai Medical Center
Treatments:
Tofacitinib